Tiziana Life Sciences Ltd (TLSA) Free cash flow 2017–2024
Tiziana Life Sciences Ltd (TLSA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.5MFY2024 · since FY2017: -$7.5M → -$1.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$1.5M | — |
| FY2021 | -$21.8M | -92.1% |
| FY2020 | -$11.3M | -66.7% |
| FY2019 | -$6.8M | — |
| FY2017 | -$7.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSA financial trends
TLSA RevenueTLSA Net incomeTLSA Net marginTLSA Gross profitTLSA Gross marginTLSA Operating incomeTLSA Operating marginTLSA Operating cash flowTLSA Capital expendituresTLSA Return on equityTLSA Stock buybacksTLSA Dividends paidTLSA Total assetsTLSA Total liabilitiesTLSA Shareholders’ equityTLSA overview →